The Impact of Colorectal Cancer Screening on Surgical Outcomes
NCT ID: NCT06416501
Last Updated: 2024-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
4000 participants
OBSERVATIONAL
2024-05-11
2024-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Data extracted from the database included the following patient information: age at diagnosis, gender, tumor location, neoadjuvant therapy, surgical procedures, histologic type, differentiation, vascular invasion, perineural invasion, pathological T stage, pathological N stage, and survival outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Cohort of Molecular Characteristics and Prognosis of Colorectal Cancer
NCT05086601
A Comparison of Different Fecal Occult Blood Test for Colorectal Cancer Screening
NCT04454099
Risk of Metachronous Advanced Colorectal Neoplastic Among Individuals With Varying Numbers of Non-Advanced Adenomas Detected During Screening Colonoscopy
NCT07302139
Early Diagnosis and Recurrence Monitoring of Colorectal Cancer
NCT06991452
Screening for Colorectal Neoplasm in First Degree Relatives of the Affected
NCT00164944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
screening
Patients who were detected through any screening test were categorized into the screening group
Mode of detection
Mode of detection
nonscreening
Patients who were detected based on symptoms formed the non-screening group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mode of detection
Mode of detection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LI XIN-XIANG
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xinxiang Li
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FudanUcf
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.